Compile Data Set for Download or QSAR

Found 417 hits Enz. Inhib. hit(s) with all data for entry = 7532   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Plasma kallikrein (Homo sapiens (Human))	BDBM200184 (US9234000, 175) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C32H34ClN5O4S/c1-2-42-25-11-9-21(10-12-25)16-28(38-32(41)29-26(33)13-15-43-29)31(40)37-27(17-24-4-3-14-35-19-24)30(39)36-20-23-7-5-22(18-34)6-8-23/h3-15,19,27-28H,2,16-18,20,34H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t27-,28+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200192 (US9234000, 183 | US9234000, 187) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200207 (US9234000, 198) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H35ClN4O5S/c1-2-43-25-14-12-21(13-15-25)18-27(37-33(42)30-26(34)16-17-44-30)31(40)38-28(29(39)24-6-4-3-5-7-24)32(41)36-20-23-10-8-22(19-35)9-11-23/h3-17,27-29,39H,2,18-20,35H2,1H3,(H,36,41)(H,37,42)(H,38,40)/t27-,28+,29-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200160 (US9234000, 151) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-23(13-15-28)18-30(36-31(38)27-6-4-3-5-7-27)33(40)37-29(19-26-16-17-42-22-26)32(39)35-21-25-10-8-24(20-34)9-11-25/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200190 (US9234000, 181) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H37N5O4S/c1-3-42-27-12-10-23(11-13-27)17-29(38-33(41)30-22(2)14-16-43-30)32(40)37-28(18-26-5-4-15-35-20-26)31(39)36-21-25-8-6-24(19-34)7-9-25/h4-16,20,28-29H,3,17-19,21,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200193 (US9234000, 184) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C30H32ClN5O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(31)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-32)4-6-21/h3-12,17-18,25-26H,2,13-16,32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200134 (US9234000, 125) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H37N5O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(35)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-34)9-11-25/h3-17,28-29H,2,18-21,34-35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200162 (US9234000, 153) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-25(17-19-30)20-32(40-35(42)28-8-4-3-5-9-28)37(44)41-33(21-29-24-46-34-11-7-6-10-31(29)34)36(43)39-23-27-14-12-26(22-38)13-15-27/h3-19,24,32-33H,2,20-23,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t32-,33+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200208 (US9234000, 199) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H39N5O4/c1-3-44-30-16-12-25(13-17-30)19-32(39-33(41)29-14-6-24(2)7-15-29)35(43)40-31(20-28-5-4-18-37-22-28)34(42)38-23-27-10-8-26(21-36)9-11-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200169 (US9234000, 160) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H39N5O5/c1-3-45-30-14-10-24(11-15-30)19-32(39-33(41)28-12-16-29(44-2)17-13-28)35(43)40-31(20-27-5-4-18-37-22-27)34(42)38-23-26-8-6-25(21-36)7-9-26/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200171 (US9234000, 162) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C32H35N5O4S/c1-2-41-26-13-11-22(12-14-26)17-28(37-32(40)29-6-4-16-42-29)31(39)36-27(18-25-5-3-15-34-20-25)30(38)35-21-24-9-7-23(19-33)8-10-24/h3-16,20,27-28H,2,17-19,21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200210 (US9234000, 201) Show SMILES NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)C(Cc2ccc(OCC(F)(F)F)cc2)NC(=O)c2ccccc2)cc1 Show InChI InChI=1S/C35H35F3N4O4/c36-35(37,38)23-46-29-17-15-25(16-18-29)20-31(41-32(43)28-9-5-2-6-10-28)34(45)42-30(19-24-7-3-1-4-8-24)33(44)40-22-27-13-11-26(21-39)12-14-27/h1-18,30-31H,19-23,39H2,(H,40,44)(H,41,43)(H,42,45)/t30-,31?/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200206 (US9234000, 197) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H38N4O5/c1-2-44-29-19-17-24(18-20-29)21-30(38-33(41)28-11-7-4-8-12-28)34(42)39-31(32(40)27-9-5-3-6-10-27)35(43)37-23-26-15-13-25(22-36)14-16-26/h3-20,30-32,40H,2,21-23,36H2,1H3,(H,37,43)(H,38,41)(H,39,42)/t30-,31+,32-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200201 (US9234000, 192) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 Show InChI InChI=1S/C35H39N5O4/c1-3-44-30-15-12-25(13-16-30)19-32(39-33(41)28-9-5-4-6-10-28)35(43)40-31(20-26-8-7-17-37-22-26)34(42)38-23-27-11-14-29(21-36)24(2)18-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200203 (US9234000, 194) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H37N5O4S2/c1-2-44-26-13-11-22(12-14-26)17-29(40-35(43)32-28(37)15-16-45-32)34(42)39-30(18-25-21-46-31-6-4-3-5-27(25)31)33(41)38-20-24-9-7-23(19-36)8-10-24/h3-16,21,29-30H,2,17-20,36-37H2,1H3,(H,38,41)(H,39,42)(H,40,43)/t29-,30+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200195 (US9234000, 186) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C36H39N5O4S/c1-3-45-28-14-12-24(13-15-28)18-30(41-36(44)33-23(2)16-17-38-33)35(43)40-31(19-27-22-46-32-7-5-4-6-29(27)32)34(42)39-21-26-10-8-25(20-37)9-11-26/h4-17,22,30-31,38H,3,18-21,37H2,1-2H3,(H,39,42)(H,40,43)(H,41,44)/t30-,31+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200197 (US9234000, 188 | US9234000, 195) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200168 (US9234000, 159) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1 Show InChI InChI=1S/C34H36ClN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200191 (US9234000, 182) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 Show InChI InChI=1S/C36H40N4O4/c1-3-44-31-18-15-27(16-19-31)22-33(39-34(41)29-12-8-5-9-13-29)36(43)40-32(21-26-10-6-4-7-11-26)35(42)38-24-28-14-17-30(23-37)25(2)20-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200128 (US9234000, 119) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C34H38N4O4S/c1-3-42-28-15-13-25(14-16-28)20-30(38-34(41)31-23(2)17-18-43-31)33(40)37-29(19-24-7-5-4-6-8-24)32(39)36-22-27-11-9-26(21-35)10-12-27/h4-18,29-30H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200192 (US9234000, 183 | US9234000, 187) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200125 (US9234000, 116) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H35ClN4O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(34)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-35)9-11-25/h3-17,28-29H,2,18-21,35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200200 (US9234000, 191) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2[nH]c(C)cc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H41N5O4/c1-4-44-29-16-14-26(15-17-29)20-31(40-35(43)32-23(2)18-24(3)38-32)34(42)39-30(19-25-8-6-5-7-9-25)33(41)37-22-28-12-10-27(21-36)11-13-28/h5-18,30-31,38H,4,19-22,36H2,1-3H3,(H,37,41)(H,39,42)(H,40,43)/t30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200133 (US9234000, 124) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C34H39N5O4/c1-3-43-28-15-13-25(14-16-28)20-30(39-34(42)31-23(2)17-18-36-31)33(41)38-29(19-24-7-5-4-6-8-24)32(40)37-22-27-11-9-26(21-35)10-12-27/h4-18,29-30,36H,3,19-22,35H2,1-2H3,(H,37,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200163 (US9234000, 154) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 Show InChI InChI=1S/C35H37FN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200164 (US9234000, 155) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1 Show InChI InChI=1S/C35H37ClN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200012 (US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200188 (US9234000, 179) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H39N5O5S/c1-3-45-28-15-13-25(14-16-28)20-31(40-35(44)32-29(17-18-46-32)38-23(2)41)34(43)39-30(19-24-7-5-4-6-8-24)33(42)37-22-27-11-9-26(21-36)10-12-27/h4-18,30-31H,3,19-22,36H2,1-2H3,(H,37,42)(H,38,41)(H,39,43)(H,40,44)/t30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200198 (US9234000, 189) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2cccc(C)c2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H39N5O4/c1-3-44-30-15-13-25(14-16-30)19-32(39-33(41)29-8-4-6-24(2)18-29)35(43)40-31(20-28-7-5-17-37-22-28)34(42)38-23-27-11-9-26(21-36)10-12-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200161 (US9234000, 152) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C32H35N5O4S/c1-2-41-27-14-12-22(13-15-27)16-28(36-30(38)25-6-4-3-5-7-25)32(40)37-29(17-26-20-42-21-35-26)31(39)34-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,39)(H,36,38)(H,37,40)/t28-,29+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200202 (US9234000, 193) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H37N5O5S2/c1-3-43-26-10-8-22(9-11-26)16-29(38-33(42)30-27(13-15-45-30)36-21(2)39)32(41)37-28(17-25-12-14-44-20-25)31(40)35-19-24-6-4-23(18-34)5-7-24/h4-15,20,28-29H,3,16-19,34H2,1-2H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/t28-,29+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	25	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200154 (US9234000, 145) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C34H37N5O4/c1-2-43-29-16-14-24(15-17-29)19-31(38-32(40)28-8-4-3-5-9-28)34(42)39-30(20-27-7-6-18-36-22-27)33(41)37-23-26-12-10-25(21-35)11-13-26/h3-18,22,30-31H,2,19-21,23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	25	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200082 (US9234000, 73) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	25	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200185 (US9234000, 176) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C37H39N5O4/c1-2-46-30-18-16-25(17-19-30)20-33(41-35(43)28-8-4-3-5-9-28)37(45)42-34(21-29-24-39-32-11-7-6-10-31(29)32)36(44)40-23-27-14-12-26(22-38)13-15-27/h3-19,24,33-34,39H,2,20-23,38H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t33-,34+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200199 (US9234000, 190) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H39N5O4/c1-3-44-29-16-14-25(15-17-29)19-32(39-33(41)30-9-5-4-7-24(30)2)35(43)40-31(20-28-8-6-18-37-22-28)34(42)38-23-27-12-10-26(21-36)11-13-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200032 (US9234000, 23) Show SMILES CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)C(=O)CC)cc1 Show InChI InChI=1S/C31H37ClN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200064 (US9234000, 55) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H37ClN4O4/c1-2-44-30-18-12-25(13-19-30)21-32(39-33(41)28-14-16-29(36)17-15-28)35(43)40-31(20-24-6-4-3-5-7-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200101 (US9234000, 92) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C36H40N4O4/c1-3-44-31-19-15-27(16-20-31)22-33(39-34(41)30-17-9-25(2)10-18-30)36(43)40-32(21-26-7-5-4-6-8-26)35(42)38-24-29-13-11-28(23-37)12-14-29/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200205 (US9234000, 196) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C34H37ClN4O4S/c1-3-43-27-15-13-24(14-16-27)19-29(38-33(41)31-28(35)17-18-44-31)34(42)39(2)30(20-23-7-5-4-6-8-23)32(40)37-22-26-11-9-25(21-36)10-12-26/h4-18,29-30H,3,19-22,36H2,1-2H3,(H,37,40)(H,38,41)/t29-,30+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200166 (US9234000, 157) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C32H35N5O4S/c1-2-41-25-14-12-22(13-15-25)18-28(36-31(39)27-7-3-4-16-34-27)32(40)37-29(19-26-6-5-17-42-26)30(38)35-21-24-10-8-23(20-33)9-11-24/h3-17,28-29H,2,18-21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	36	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200197 (US9234000, 188 | US9234000, 195) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	36	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200088 (US9234000, 79) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C32H35N5O5/c1-2-41-26-14-12-23(13-15-26)19-28(37-32(40)29-16-17-35-42-29)31(39)36-27(18-22-6-4-3-5-7-22)30(38)34-21-25-10-8-24(20-33)9-11-25/h3-17,27-28H,2,18-21,33H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	38	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200140 (US9234000, 131) Show SMILES CCCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C36H40N4O4/c1-2-21-44-31-19-17-27(18-20-31)23-33(39-34(41)30-11-7-4-8-12-30)36(43)40-32(22-26-9-5-3-6-10-26)35(42)38-25-29-15-13-28(24-37)14-16-29/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200090 (US9234000, 81) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C34H37N5O4/c1-2-43-28-17-15-25(16-18-28)21-31(39-33(41)29-10-6-7-19-36-29)34(42)38-30(20-24-8-4-3-5-9-24)32(40)37-23-27-13-11-26(22-35)12-14-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,40)(H,38,42)(H,39,41)/t30-,31+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200187 (US9234000, 178) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C36H37N5O4S/c1-2-45-29-13-11-24(12-14-29)19-31(40-34(42)27-15-17-38-18-16-27)36(44)41-32(20-28-23-46-33-6-4-3-5-30(28)33)35(43)39-22-26-9-7-25(21-37)8-10-26/h3-18,23,31-32H,2,19-22,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	42	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200178 (US9234000, 169) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H34Cl2N4O4S/c1-2-43-25-12-9-21(10-13-25)17-29(39-33(42)30-4-3-15-44-30)32(41)38-28(18-24-11-14-26(34)27(35)16-24)31(40)37-20-23-7-5-22(19-36)6-8-23/h3-16,28-29H,2,17-20,36H2,1H3,(H,37,40)(H,38,41)(H,39,42)/t28-,29+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200183 (US9234000, 174) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C31H34N6O5/c1-2-41-25-11-9-21(10-12-25)16-27(37-31(40)28-13-15-35-42-28)30(39)36-26(17-24-4-3-14-33-19-24)29(38)34-20-23-7-5-22(18-32)6-8-23/h3-15,19,26-27H,2,16-18,20,32H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t26-,27+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200209 (US9234000, 200) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C35H36F2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200149 (US9234000, 140) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C34H37N5O4/c1-2-43-29-17-15-24(16-18-29)20-30(38-32(40)27-8-4-3-5-9-27)34(42)39-31(21-28-10-6-7-19-36-28)33(41)37-23-26-13-11-25(22-35)12-14-26/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM200081 (US9234000, 72) Show SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccsc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 Show InChI InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-24(13-15-28)19-30(36-31(38)27-16-17-42-22-27)33(40)37-29(18-23-6-4-3-5-7-23)32(39)35-21-26-10-8-25(20-34)9-11-26/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	46	n/a	n/a	n/a	n/a	n/a	n/a
Kalvista Pharmaceuticals Limited US Patent					Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...				US Patent US9234000 (2016) BindingDB Entry DOI: 10.7270/Q2X065W0
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 417 total )  |  Next  |  Last  >>

Jump to: